ttnp stock forecast zacks

Ad The Zacks Rank helps you make well-informed buy and sell decisions. Since then TTNP shares have decreased by 864 and is now trading at 100.

Speculation Stocks Message Board Investorshub

Find the latest Titan Pharmaceuticals Inc.

. Youll find the Titan Pharmaceuticals Inc. NASDAQ Updated Mar 18 2022 1114 PM TTNP 094 006 580. Wall Street Stock Market Finance report prediction for the future.

Titan Pharmaceuticals Greek Montage stock information. Get the latest Detailed Estimate from Zacks Investment Research. Titan Pharmaceuticals NASDAQTTNP Price Target and Consensus Rating.

Ad Join 500k Active Members Who Follow Our Free Penny Stock Picks. View Titan Pharmaceuticals Inc TTNP investment stock information. Titan Pharmaceuticals Detailed Estimate.

Read our earnings report guide before you consider the forecast information when. Considering analysts have assigned the stock a price target range of 700-700 as the low and high respectively we find the trailing 12-month average consensus price target to be 700. Fundamental company data provided by Zacks Investment Research.

View Titan Pharmaceuticals NASDAQTTNP earnings history next earnings date earnings forecasts and conference call transcripts from top-rated Wall Street analysts at MarketBeat. Debt was carried at 40 million. Ad Seize Powerful Financial Analysis Opportunities With Eikon.

Check our latest stock ranks on hundreds of stocks and see exclusive commentary FREE. Cash and equivalents as of June 30 2019 were 23 million compared to 93 million at the end of 2018. An industry ratio of -1290 implying that they will have a.

Cash burn was 42 million in 2Q19 compared to 19 million in the comparable prior year period. De share forecasts stock quote and buy sell signals belowAccording to present data Titan Pharmaceuticals Inc. Common Stock TTNP.

Click here - the TTNP analysis is free About 12 Month EPS. Titan Pharmaceuticals stock was trading at 73350 on March 11th 2020 when COVID-19 reached pandemic status according to the World Health Organization WHO. Click here - the TTNP analysis is free Zacks News for TTNP.

TTNP stock quote history news and other vital information to help you with your stock trading and investing. During the quarter Titan received 571000 from exercise of warrants and stock issuance. Des TTNP shares and.

Penny Stock Traders Have Made Huge Profits. Get the latest balance sheet from Zacks Investment Research. Titan Pharmaceuticals balance sheet.

View which stocks have been most impacted by COVID-19. De Stock Market info Recommendations. Find real-time TTNP - Titan Pharmaceuticals Inc stock quotes company profile news and forecasts from CNN Business.

Have Full Confidence In Your Investment Decisions Management Strategies With Eikon Today. Zacks Investment Research is releasing its prediction for TTNP based on the 1-3 month trading system that nearly triples the SP 500. TTNP abandoned its efforts to commercialize Probuphine and has refocused its activities on the development portfolio.

The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 700 with a high estimate of 700 and a low estimate of 700. TTNP abandoned its efforts to commercialize Probuphine and has. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months.

Zacks Investment Research is releasing its prediction for TTNP based on the 1-3 month trading system that nearly triples the SP 500. Buy or sell Titan Pharmaceuticals Inc. Information about which ETFs are holding the stock TTNP Titan Pharmaceuticals Inc DE from ETF Channel.

By John Vandermosten NASDAQTTNP READ THE FULL TTNP RESEARCH REPORT Third Quarter 2020 Financial and Operational Results Titan Pharmaceuticals Inc. Titan has been actively working on the nalmefene. Get the latest Greek Montage stock quote information from Zacks Investment Research.

Get the latest Titan Pharmaceuticals Inc TTNP detailed stock. Standard investment valuation methodologies to the revenue and EPS forecasts made by the SCR Analyst of the issuers business. Based on this estimate we see that current price is roughly -64468 off the estimated low and -64468 off the forecast high.

Zacks Investment Research reports that the 2020 Price to Earnings ratio for TTNP is -229 vs. Titan Pharmaceuticals Inc. Each analysts rating is normalized to a standardized rating score of 1 sell 2 hold 3 buy or 4.

Speculation Stocks Message Board Investorshub